Scholarlink

Objective <p>Primary graft dysfunction, largely caused by ischemia–reperfusion injury (IRI), remains a major determinant of outcomes after lung transplantation. While protective perfusion, achieved by reducing perfusion pressure and flow, has been shown to mitigate lung IRI, the effect of oxygenated blood perfusion remains unclear. We developed an in vivo model using extracorporeal membrane oxygenation (ECMO) to control perfusion pressure and oxygen tension in perfusion blood of ischemic lungs and evaluated its potential protective effects against lung IRI.</p> Methods <p>A porcine IRI model was established by clamping the left pulmonary hilum for 2.5&#xa0;h. After reperfusion, animals were assigned to three groups: the control group, which received only lung rest ventilation; the veno-arterial ECMO (VA-ECMO) group; and the combined veno-arterial and veno-pulmonary artery ECMO (cVPA-ECMO) group, in which oxygenated blood was additionally delivered into the left pulmonary artery (PA). Each group underwent a 4-h intervention period followed by a 4-h observation phase.</p> Results <p>Both ECMO groups showed improvements in pulmonary function, hemodynamics, tissue injury, edema, cell death, and inflammatory markers compared with controls, suggesting attenuation of IRI. However, no significant differences were found between the VA-ECMO and cVPA-ECMO groups in any evaluated parameter, and no clear additive benefit from oxygenated blood delivery to the PA was observed.</p> Conclusions <p>In lung IRI, oxygenated blood perfusion showed no additive benefit beyond the protective effect of flow control. These findings suggest that ventilation-based oxygenation and hemodynamic management play a greater role in attenuating IRI.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Oxygenated blood perfusion provides no additional benefit beyond flow control in lung ischemia–reperfusion injury

  • 期刊论文

  • 发表日期：

    2025年12月16日

查看全文
  • Tsuyoshi Ryuko,
  • Kentaroh Miyoshi,
  • Kei Matsubara,
  • Shin Tanaka,
  • Ken Suzawa,
  • Toshiaki Ohara,
  • Mikio Okazaki,
  • Seiichiro Sugimoto,
  • Akihiro Matsukawa,
  • Shinichi Toyooka

摘要

Objective

Primary graft dysfunction, largely caused by ischemia–reperfusion injury (IRI), remains a major determinant of outcomes after lung transplantation. While protective perfusion, achieved by reducing perfusion pressure and flow, has been shown to mitigate lung IRI, the effect of oxygenated blood perfusion remains unclear. We developed an in vivo model using extracorporeal membrane oxygenation (ECMO) to control perfusion pressure and oxygen tension in perfusion blood of ischemic lungs and evaluated its potential protective effects against lung IRI.

Methods

A porcine IRI model was established by clamping the left pulmonary hilum for 2.5 h. After reperfusion, animals were assigned to three groups: the control group, which received only lung rest ventilation; the veno-arterial ECMO (VA-ECMO) group; and the combined veno-arterial and veno-pulmonary artery ECMO (cVPA-ECMO) group, in which oxygenated blood was additionally delivered into the left pulmonary artery (PA). Each group underwent a 4-h intervention period followed by a 4-h observation phase.

Results

Both ECMO groups showed improvements in pulmonary function, hemodynamics, tissue injury, edema, cell death, and inflammatory markers compared with controls, suggesting attenuation of IRI. However, no significant differences were found between the VA-ECMO and cVPA-ECMO groups in any evaluated parameter, and no clear additive benefit from oxygenated blood delivery to the PA was observed.

Conclusions

In lung IRI, oxygenated blood perfusion showed no additive benefit beyond the protective effect of flow control. These findings suggest that ventilation-based oxygenation and hemodynamic management play a greater role in attenuating IRI.